Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors

We describe the presentation of patients developing endophthalmitis after intravitreal injection with vascular endothelial growth factor (VEGF) inhibitors. Moreover, we evaluate the management by comparing the outcomes of immediate tap and injection of intravitreal antibiotics (TAI) versus initial surgical pars plana vitrectomy (PPV). Finally, we analyze the predictive factors of visual outcomes at 6-month follow-up.

Source: Ophthalmology - February 21, 2018 Category: Opthalmology Authors: Kunyong Xu, Eric K. Chin, Steven R. Bennett, David F. Williams, Edwin H. Ryan, Sundeep Dev, Robert A. Mittra, Polly A. Quiram, John B. Davies, D. Wilkin Parke, Jill B. Johnson, Herbert L. Cantrill, David R.P. Almeida Source Type: research